Fig. 4From: Integrative analysis and experiments to explore angiogenesis regulators correlated with poor prognosis, immune infiltration and cancer progression in lung adenocarcinomaEvaluation of the response sensitivity of chemotherapeutic drugs and molecular targeted drugs in high- and low-risk patients. A–D Therapeutic response to chemotherapy drugs between high- and low-risk patients. E–L Therapeutic response of targeted gene drugs of patients with LUAD in high- and low-risk groupsBack to article page